M-GAGER
Live / Registered — Registered (as of 10 Oct 2023)
What this means for you
Registered since 10 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97334920
- Registration number
- 7186176
- Mark type
- Stylized text
- Filed
- 28 Mar 2022
- Published for opposition
- 25 Jul 2023
- Registered
- 10 Oct 2023
- Attorney of record
- David M. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Biochemical preparations for medical use, namely for use in the treatment of cancer; Biological preparations for medical purposes, namely for use in the treatment of cancer; biotechnological products for medical use, namely medical preparations for the treatment of cancer; Pharmaceuticals for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatory preparations; Immunostimulants; Medicines for human purposes namely, medicinal preparations for the treatment of cancer; Medicines for veterinary purposes namely, veterinary pharmaceutical preparations for the treatment of cancer; Chemico-pharmaceutical preparations namely, chemical preparations for pharmaceutical or medical purposes, namely for use in the treatment of cancer; Diagnostic agents for medical use; Pharmaceuticals, medical and veterinary preparations, namely pharmaceutical preparations for use in the treatment of cancer
- Class 042 — Scientific and technological services: Scientific and medical research and development in the field of cancer; Biological and chemical research; Research relating to biotechnology; Pharmaceutical research and development; Research and development services in the field of immunology; Laboratory analysis in the field of molecular biology; Provision of information relating to medical and veterinary research and development in the field of cancer; Consultancy in the field of pharmaceutical research; Consultancy relating to research and development in the field of therapeutics; consultancy relating to biotechnology; Scientific laboratory services; Analytical laboratory services, namely, laboratory analysis in the field of cancer; Services of a chemical or biological laboratory, namely, chemical and biological research and analysis; Research and development services for the pharmaceutical industry; Product development; Quality control for others; Research and development services in the field of antibodies; Scientific research services in the field of proteins, antibodies, microorganisms and cells; Scientific and technological services, namely, scientific analysis and research services in the field of cancer; Chemical analysis; Medical and scientific research, namely, conducting clinical trials for others; Providing of information relating to medical and scientific research on pharmaceutical products
Owner
- CDR-Life AG, Horgen, CH
- CDR-Life AG, Schlieren-Zurich, CH
- CDR-Life AG, Schlieren-Zurich, CH
Prosecution history
- 07 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Dec 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Dec 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Dec 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Dec 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jul 2023 — PUBLISHED FOR OPPOSITION
- 05 Jul 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 May 2023 — EXAMINER'S AMENDMENT ENTERED
- 22 May 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 May 2023 — EXAMINERS AMENDMENT E-MAILED
- 22 May 2023 — EXAMINERS AMENDMENT -WRITTEN